According to the data of , as of 17:00 p.m. on January 27, a total of 1501 A-share listed companies disclosed performance forecasts for 2021, and 1115 were expected to be happy, with a pre happy rate of 74.28%. Among them, 770 listed companies previously disclosed the consensus expectation of the market. According to the lower limit of net profit attributable to shareholders of Listed Companies in 2021, the net profit of 159 companies exceeded the expectation. From the perspective of the industry of listed companies exceeding expectations, the number of supermarkets of Listed Companies in medicine, new energy vehicles, coal and logistics is higher than expected.
in addition to the annual report performance forecast, Huasu Holdings Co.Ltd(000509) , Shandong Wohua Pharmaceutical Co.Ltd(002107) , Beijing Compass Technology Development Co.Ltd(300803) , Shanghai Kaikai Industry Company Limited(600272) and other listed companies have disclosed the annual report of 2021.
the first batch of annual reports are released
The first 2021 annual report of Shanghai stock market was released on the evening of January 27. In 2021, the company achieved a total operating income of 670 million yuan, a year-on-year decrease of 12.08%; The net profit attributable to the shareholders of the listed company was about 21.7172 million yuan, a year-on-year increase of 58.81%. It is proposed to distribute profits based on the total share capital registered on the date of equity distribution and equity registration, and distribute a cash dividend of RMB 0.27 (including tax) for every 10 shares to all shareholders, with a total dividend of RMB 6.561 million.
Shanghai Kaikai Industry Company Limited(600272) said that affected by the market environment, changes in medical reform policies and repeated epidemics, the operating income decreased year by year, affecting the profitability of the company.
Previously, Huasu Holdings Co.Ltd(000509) , Shandong Wohua Pharmaceutical Co.Ltd(002107) , Beijing Compass Technology Development Co.Ltd(300803) and other Shenzhen Stock Exchange listed companies have disclosed the annual report of 2021.
Among the listed companies that have disclosed their annual reports, Shandong Wohua Pharmaceutical Co.Ltd(002107) intends to pay a higher proportion of dividends. Shandong Wohua Pharmaceutical Co.Ltd(002107) in 2021, the operating revenue was about 943 million yuan, a year-on-year decrease of 6.3%; The net profit attributable to the parent company was 163 million yuan, a year-on-year decrease of 8.66%. The company plans to distribute a cash dividend of 2.6 yuan (including tax) to all shareholders for every 10 shares.
Beijing Compass Technology Development Co.Ltd(300803) is the first listed company on the gem to disclose the annual report of 2021. During the reporting period, the company achieved a total operating revenue of about 932 million yuan, a year-on-year increase of 34.63%; The net profit attributable to the shareholders of the listed company was about 176 million yuan, a year-on-year increase of 97.51%.
overall maintain a good profitability
According to the data, as of 17:00 p.m. on January 27, a total of 1501 A-share listed companies disclosed 2021 performance forecasts, and 1115 were expected to be happy, with a pre happy rate of 74.28%. Among them, 177 companies increased slightly, 146 companies reversed losses, 25 companies continued to make profits, and 767 companies increased in advance. The listed companies that have disclosed the performance forecast have maintained high profitability as a whole.
In terms of net profit, it is expected that 881 companies will realize the lower limit of net profit attributable to shareholders of Listed Companies in 2021, 205 companies are expected to exceed 1 billion yuan, 69 companies are expected to exceed 3 billion yuan and 11 companies are expected to exceed 10 billion yuan. China Mobile, Petrochina Company Limited(601857) , Cosco Shipping Holdings Co.Ltd(601919) , Kweichow Moutai Co.Ltd(600519) , Boe Technology Group Co.Ltd(000725) , Wanhua Chemical Group Co.Ltd(600309) has the highest lower limit of net profit attributable to shareholders of listed companies.
In terms of net profit growth rate, excluding the impact of loss reversing companies, 938 companies are expected to realize the lower limit of net profit growth attributable to shareholders of listed companies by 2021, 359 companies are expected to exceed 100%, and 53 companies are expected to exceed 500%. Sichuan Hebang Biotechnology Co.Ltd(603077) , Inner Mongoliayuan Xing Energy Company Limited(000683) , Beijing Haohua Energy Resource Co.Ltd(601101) , Chengxin Lithium Group Co.Ltd(002240) , Hengbao Co.Ltd(002104) the lower limit of net profit growth attributable to shareholders of listed companies ranked first.
From the perspective of industry, there are a large number of Listed Companies in chemical, electronic, semiconductor, biomedicine, steel, coal and other industries. Some listed companies in traditional industries, represented by iron and steel, experienced a decline in single quarter growth in the fourth quarter due to comprehensive factors such as rising prices of raw materials such as coal and lower than expected downstream real estate infrastructure, resulting in a decline in annual performance growth compared with the first three quarters.
performance of several companies exceeded expectations
The reporter of China Securities Journal found that among the 1501 listed companies that have disclosed the performance forecast of 2021, 770 listed companies have previously disclosed the consensus expectations of the market. Calculated by the lower limit of performance forecast, the data show that at present, the lower limit of net profit attributable to shareholders of listed companies of 159 companies in 2021 exceeds the consensus expectation of the market, accounting for 10.59% of all companies with disclosed performance forecast.
From the perspective of the industry of listed companies exceeding expectations, the number of supermarkets of Listed Companies in medicine, new energy vehicles, coal and logistics is higher than expected.
Benefiting from the continuous rise of coal prices in 2021, Shanxi Coal International Energy Group Co.Ltd(600546) , Jinneng Holding Shanxi Coal Industry Co.Ltd(601001) and other coal listed companies are expected to go to supermarkets. Taking Shanxi Coal International Energy Group Co.Ltd(600546) as an example, the company expects to realize a net profit of 4.5 billion yuan to 5 billion yuan attributable to shareholders of Listed Companies in 2021, with a year-on-year increase of 444.14% to 504.59%. Shanxi Coal International Energy Group Co.Ltd(600546) the net profit attributable to shareholders of Listed Companies in 2021 is expected to be about 3.863 billion yuan. The main reason for the performance growth is that the company’s profitability has increased significantly due to the continuous improvement of the prosperity of the coal industry and the continuous rise of coal market prices; The company comprehensively implemented lean management, scientifically controlled costs, moderately released advanced production capacity, ensured energy supply, and greatly optimized asset quality.
Pharmaceutical listed companies benefited from the continuous increase in downstream demand, and the performance of many vaccine listed companies significantly exceeded expectations.
Chongqing Zhifei Biological Products Co.Ltd(300122) it is estimated that the net profit attributable to shareholders of listed companies will reach about 9.904 billion yuan to 10.564 billion yuan in 2021, with a year-on-year increase of 200% to 220%. Chongqing Zhifei Biological Products Co.Ltd(300122) the net profit attributable to shareholders of Listed Companies in 2021 is unanimously expected to be about 7 billion yuan. For the main reasons for performance changes, the company said that the company has always attached importance to R & D and innovation to meet the changing needs of disease prevention and control. At the same time, it organically combines leading R & D technology with efficient market promotion, forming a virtuous circle guided by market demand and promoted development through R & D and innovation, which has promoted the long-term, steady and sustainable development of the company. During the reporting period, the company continued to focus on business development objectives, increased R & D investment, pushed through the old and brought forth the new, continued to steadily improve the sales of independent products and agency products, and the company’s main business income, net profit and other important financial indicators will increase significantly compared with the same period of last year.
